Last reviewed · How we verify
Betneval ointment - Non-desquamated zone
Betneval ointment - Non-desquamated zone is a Small molecule drug developed by Galderma R&D. It is currently in Phase 2 development. Also known as: Betamethasone Valerate.
At a glance
| Generic name | Betneval ointment - Non-desquamated zone |
|---|---|
| Also known as | Betamethasone Valerate |
| Sponsor | Galderma R&D |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Betneval ointment - Non-desquamated zone CI brief — competitive landscape report
- Betneval ointment - Non-desquamated zone updates RSS · CI watch RSS
- Galderma R&D portfolio CI
Frequently asked questions about Betneval ointment - Non-desquamated zone
What is Betneval ointment - Non-desquamated zone?
Betneval ointment - Non-desquamated zone is a Small molecule drug developed by Galderma R&D.
Who makes Betneval ointment - Non-desquamated zone?
Betneval ointment - Non-desquamated zone is developed by Galderma R&D (see full Galderma R&D pipeline at /company/galderma-r-d).
Is Betneval ointment - Non-desquamated zone also known as anything else?
Betneval ointment - Non-desquamated zone is also known as Betamethasone Valerate.
What development phase is Betneval ointment - Non-desquamated zone in?
Betneval ointment - Non-desquamated zone is in Phase 2.
Related
- Manufacturer: Galderma R&D — full pipeline
- Also known as: Betamethasone Valerate
- Compare: Betneval ointment - Non-desquamated zone vs similar drugs
- Pricing: Betneval ointment - Non-desquamated zone cost, discount & access